Article
Clinical and immunological assessment of APDS2 with features of the SHORT syndrome related to a novel mutation in PIK3R1 with reduced penetrance.
Allergologia et immunopathologia - 1 Jan 2022
Szczawińska-Popłonyk Aleksandra, Bernat-Sitarz Katarzyna, Schwartzmann Eyal, Piechota Michał, Badura-Stronka Magdalena
Abstract excerpt
Monoallelic loss-of-function (LOF) mutations in the phosphatidylinositol 3-kinase (PIK3R1) gene affecting the inter-Src homology 2 domain of the p85α regulatory subunit of phosphoinositide--3-kinase δ (PI3Kδ) cause the activated PI3K δ syndrome (APDS2). APDS2 is defined as a primary antibody deficiency, developmental abnormalities within the B and T lymph cell compartments, and immune dysregulation. The genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
